Conmed (CNMD) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Powered by 
Analysis
Conmed (CNMD) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 22.97% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 51.47% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -7.83% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 17.54% |
| 10 | Conmed | 1.48 Bn | 1.44 Bn | 197.46 Mn | 18.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.88% |
| Mar 31, 2026 | 96.63% |
| Dec 31, 2025 | -14.29% |
| Sep 30, 2025 | -60.43% |
| Jun 30, 2025 | 28.61% |
| Mar 31, 2025 | -26.13% |
| Dec 31, 2024 | 11.36% |
| Sep 30, 2024 | 48.53% |
| Jun 30, 2024 | 31.14% |
| Mar 31, 2024 | 25.97% |
| Dec 31, 2023 | 31.60% |
| Sep 30, 2023 | 32.23% |
| Jun 30, 2023 | 35.74% |
| Mar 31, 2023 | -32.55% |
| Dec 31, 2022 | 21.19% |
| Sep 30, 2022 | 87.78% |
| Jun 30, 2022 | -215.99% |
| Mar 31, 2022 | 144.78% |
| Dec 31, 2021 | 16.02% |
| Sep 30, 2021 | 36.91% |